Seyon Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.50 M
as on 17-07-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -39.59%
(FY 2023)
- Ebitda -17.32%
(FY 2023)
- Net Worth -14.94%
(FY 2023)
- Total Assets -1.97%
(FY 2023)
About Seyon Biosciences
The Company is engaged in the Life Science Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sivaraman Kandasamy, Elavarasan Subramanian, and Rangasamy Kulandaivelu serve as directors at the Company.
- CIN/LLPIN
U73100TZ2020PTC033604
- Company No.
033604
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Seyon Biosciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivaraman Kandasamy  | Director | 02-Mar-2020 | Current |
| Elavarasan Subramanian | Director | 17-Jul-2020 | Current |
| Rangasamy Kulandaivelu | Director | 02-Mar-2020 | Current |
Financial Performance and Corporate Structure Insights of Seyon Biosciences.
Seyon Biosciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 39.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Seyon Biosciences?
In 2023, Seyon Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
12 years 7 months Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Seyon Biosciences?
Unlock and access historical data on people associated with Seyon Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seyon Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seyon Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
